Keywords: myriad, gets, 24m, euro, pharma, firm, genetics
Myriad gets $24M from Euro pharma firm
Article | 30 June 2000
Myriad Genetics says it has received a $24 million equity investmentfrom a European pharmaceutical company in exchange for 300,000 shares of newly-issued ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
